|
2008 International Symposium
|
1R13CA135806-01
|
$7,000
|
$1,750
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
5-LOX-1 and Clinical Chemoprevention of Colon Tumors
|
5R01CA106577-04
|
$437,535
|
$437,535
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$723,052
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A novel sulindac derivative for colon cancer chemoprevention
|
5R03CA128021-02
|
$110,049
|
$110,049
|
PIAZZA, GARY
|
SOUTHERN RESEARCH INSTITUTE
|
|
A pilot study of statin therapy and risk of malignant glioma
|
1K07CA127468-01A1
|
$135,513
|
$135,513
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A study evaluating the effect of flaxseed on biomarkers of breast cancer risk
|
1R21CA124116-01A2
|
$209,467
|
$209,467
|
Kulkarni, Swati
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Aberrant Crypt Foci as a Biomarker for Chemoprevention
|
5R01CA113681-03
|
$1
|
$1
|
SINICROPE, FRANK
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$1,046
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$2,500
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$73,266
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Action of Novel Retinyl Ethers in Breast Cancer Control
|
5R01CA108498-05
|
$281,848
|
$281,848
|
SANI, BRAHMA
|
CHEMOPREVENTIA, LLC
|
|
Activation of the Cancer Preventive Nrf2-ARE Pathway by Seaweed
|
1R21CA133681-01A1
|
$200,906
|
$200,906
|
LUESCH, HENDRIK
|
UNIVERSITY OF FLORIDA
|
|
Altered Arachidonic Acid Balance and Colon Cancer
|
5R01CA114635-03
|
$311,403
|
$155,702
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
AN EXPLORATORY STUDY TO IDENTIFY POTENTIAL SURROGATE ENDPOINT BIOMARKERS THAT ARE
|
N01CN095139-013
|
|
$0
|
EUHUS, DAVID
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
ANDROGEN RECEPTOR SIGNALING IN SELENIUM CHEMOPREVENTION
|
7K01CA114252-04
|
$161,349
|
$161,349
|
DONG, YAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-04
|
$288,389
|
$288,389
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Animal Model for Local Inflammation-Induced Breast Cancer
|
5R03CA117486-02
|
$75,750
|
$75,750
|
NAKSHATRI, HARIKRISHNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Annual San Antonio Breast Cancer Symposium
|
5R13CA119860-03
|
$5,000
|
$500
|
COLTMAN, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Annual Uterine Cancer Symposium
|
5R13CA113095-05
|
$971
|
$97
|
LU, KAREN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Anti-cancer mechanisms of COX/LOX inhibitor licofelone on prostate carcinogenesis
|
1R03CA133929-01A1
|
$80,000
|
$80,000
|
Narayanan, Narayanan
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Anticarcinogenic Mechanisms of Tea Constituents
|
2R37CA081064-09
|
$282,625
|
$282,625
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antiestrogen Regulation of Bladder Cancer
|
1R03CA119271-01A2
|
$76,750
|
$76,750
|
SMITH, CAROLYN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antioxidants and Antiinflammatory in Colorectal Cancer
|
2R01CA073674-10
|
$276,945
|
$276,945
|
KONG, AH-NG
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-04
|
$251,966
|
$75,590
|
JONES, DAVID
|
UNIVERSITY OF UTAH
|
|
APC mutation and breast cancer: Prevention by curcumin
|
5R01CA122394-03
|
$289,553
|
$289,553
|
Katdare, Meena
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Apoptotic mechanisms in NSAID chemoprevention
|
5R01CA109012-04
|
$251,966
|
$251,966
|
Dambrosio, Steven
|
OHIO STATE UNIVERSITY
|
|
Applications of New Mass Spectral Techniques
|
Z01 BC 006178
|
$373,173
|
$37,317
|
Kelley, James
|
CCR (NCI)
|
|
Are anthocyanins necessary for oral cancer chemoprevention by berries?
|
1R03CA137798-01
|
$75,000
|
$75,000
|
WEGHORST, CHRISTOPHER
|
OHIO STATE UNIVERSITY
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$2,021,498
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$51,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Aspirin pharmacogenetics in the Aspirin/Folate Polyp Prevention Trial
|
1R03CA136026-01
|
$103,275
|
$103,275
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Assessing the Impact of Colorectal Cancer Screening
|
5U01CA097427-07
|
$215,923
|
$75,573
|
RUTTER, CAROLYN
|
CENTER FOR HEALTH STUDIES
|
|
ATBC Study
|
Z01 CP010195-03031
|
$759,338
|
$151,868
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
2U10CA045450-22
|
$761,812
|
$60,945
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-07
|
$2,374,129
|
$237,413
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$38,496
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$4,691
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$60,600
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-07
|
$1,049,588
|
$83,967
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beta-catenin-specific regulation of the vitamin D pathway in colon cancer
|
1R01CA129813-01A1
|
$318,513
|
$318,513
|
BYERS, STEPHEN
|
GEORGETOWN UNIVERSITY
|
|
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention
|
1R01CA131413-01A1
|
$313,325
|
$156,663
|
UMAR, SHAHID
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Biobehavioral Cancer Prevention and Control Training Program
|
5R25CA092408-08
|
$515,105
|
$515,105
|
Patrick, Donald
|
UNIVERSITY OF WASHINGTON
|
|
Biochemical Mechanisms of Se Anticancer Activity in Lung
|
1R01CA118434-01A2
|
$307,100
|
$307,100
|
FAN, TERESA
|
UNIVERSITY OF LOUISVILLE
|
|
Biology of the Prostate Cancer Prevention Trial (PCPT)
|
5P01CA108964-04
|
$2,747,394
|
$2,747,394
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Biomarkers to Assess Selenium Chemoprevention for NSCLC
|
2R01CA095568-06
|
$661,128
|
$661,128
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Bladder Cancer Chemoprevention with Allyl Isothiocyanate
|
1R01CA124627-01A2
|
$352,007
|
$352,007
|
ZHANG, YUESHENG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Bmi-1 and Skin Cancer Prevention
|
1R01CA131074-01A1
|
$448,570
|
$448,570
|
ECKERT, RICHARD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Botanical-derived drug discovery for cancer therapy
|
1R43CA114876-01A2
|
$130,207
|
$130,207
|
Norris, Andrew
|
BCN BIOSCIENCES, LLC
|
|
BRCA Genes in Breast Cancer Chemoprevention
|
5R01CA104546-04
|
$286,128
|
$114,451
|
ROSEN, ELIOT
|
GEORGETOWN UNIVERSITY
|
|
Breast Cancer Biomarkers for Risk and Detection
|
5K01CA111867-03
|
$134,298
|
$134,298
|
Frank, Denise
|
UNIVERSITY OF ARIZONA
|
Total relevant funding to Chemoprevention for this search: $168,074,275
|